N
The startup has developed a decellularization process that extracts DNA and donor cells from human breast tissue, preserving essential proteins and structural integrity. This technology enables breast cancer survivors to regenerate a more natural nipple and areola by repopulating the tissue with their own cells.
Updated 3 months ago
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a decellularization process that extracts DNA and donor cells from human breast tissue, preserving essential proteins and structural integrity. This technology enables breast cancer survivors to regenerate a more natural nipple and areola by repopulating the tissue with their own cells.